Home - News

"Excuuuse me?... No news?"

 

Certainly, there is news. Tapadar Pharma Compliance was joined by yet

a further dedicated employee. 

 

We warmly welcome

 Ms Ruth Wassmer as Head Administration and Professional Support

 to our team.

 

 Furthermore, for the active substance Nitisonine, Tapadar Pharma Compliance

obtained the Orphan Drug status from Swissmedic. Currently, a marketing

authorisation for Switzerland is pursued. 

 

 

"It is more important being able to count on your employees than counting them."

Aba Assa